BC Week In Review | Feb 22, 2019
Financial News

BiomX raises $32M series B to bring first two therapies to clinic

Phage therapy company BiomX Ltd. (Ness Ziona, Israel) raised a $32 million series B round on Feb. 20 that will take its lead candidate, acne therapy BX001, into the clinic within the next few months....
BC Extra | Feb 20, 2019
Financial News

BiomX raises $32M series B to bring first two therapies to clinic

Phage therapy company BiomX Ltd. (Ness Ziona, Israel) raised a $32 million series B round on Wednesday that will take its lead candidate, acne therapy BX001, into the clinic within the next few months. The...
BC Innovations | Apr 6, 2018
Targets & Mechanisms

GI Band-Aid

A trio of Science papers shows a leaky gut can drive systemic inflammation and autoimmunity by allowing bacteria and their products to escape the GI lumen and enter the bloodstream. The results open a variety...
BC Innovations | Feb 9, 2018
Product R&D

Debugging the microbiome

BiomX Ltd. is moving phage therapies beyond infectious disease and into chronic conditions driven by the microbiome. The Israeli biotech has pieced together a suite of tools that can identify bad actors within microbial communities...
BC Week In Review | Feb 2, 2018
Company News

BiomX licenses new microbiome targets

Microbiome company BiomX Ltd. (Ness Ziona, Israel) said it exclusively sublicensed a set of new bacterial targets from JSR Corp. (Tokyo:4185) to develop and commercialize bacteriophage-based therapies for inflammatory bowel disease (IBD). BiomX is using...
BC Extra | Jan 30, 2018
Company News

BiomX licenses new microbiome targets

Microbiome company BiomX Ltd. (Ness Ziona, Israel) said it exclusively sublicensed a set of new bacterial targets from JSR Corp. (Tokyo:4185) to develop and commercialize bacteriophage-based therapies for inflammatory bowel disease (IBD). BiomX is using...
BC Week In Review | Dec 22, 2017
Company News

BiomX acquires microbiome company RondinX

BiomX Ltd. (Ness Ziona, Israel) acquired fellow microbiome company RondinX (Tel Aviv, Israel), including its computational discovery platform. BiomX said it also gains a pipeline of undisclosed microbial targets that are being validated to treat...
BC Extra | Dec 19, 2017
Company News

BiomX acquires microbiome company RondinX

BiomX Ltd. (Ness Ziona, Israel) said it acquired fellow microbiome company RondinX (Tel Aviv, Israel), including its computational discovery platform. BiomX said it also gains a pipeline of undisclosed microbial targets that are being validated...
BioCentury | May 19, 2017
Finance

BiomX’s balance

After identifying a handful of novel bacterial targets and bacteriophage candidates, BiomX Ltd. was able to attract $24 million in series A funding from some of industry's most active microbiome players. OrbiMed Advisors, the Johnson...
Items per page:
1 - 9 of 9